Listed

Cardiff Oncology, Inc.

CRDFNasdaqCIK 1213037HealthcareFiscal year ends Dec 31

Reports and events: 516 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Cardiff Oncology, Inc., Reports and events
FiledFormWhat it isAccession number
2026-11-1216:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-458500
2026-11-1216:20 ET10-QQuarterly reportPeriod 2026-09-300001193125-26-458485
2026-10-2716:44 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-048720
2026-10-2216:30 ET8-K5.07 Shareholder vote results0001493152-26-048111
2026-09-1409:28 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-26-042506
2026-08-2616:01 ETDEF 14AProxy statementPeriod 2026-08-260001193125-26-368249
2026-08-1116:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-344645
2026-08-1116:01 ET10-QQuarterly reportPeriod 2026-06-300001193125-26-344545
2026-07-1608:38 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-305467
2026-06-1116:15 ET8-K5.07 Shareholder vote results0001193125-26-267563
2026-06-0308:30 ET8-K7.01 Regulation FD disclosure0001193125-26-254658
2026-05-2917:11 ET8-K1.01 Entry into a material agreement0001193125-26-248711
2026-05-1917:01 ET8-K8.01 Other events0001193125-26-231040
2026-05-1416:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213037-26-000013
2026-05-1416:00 ET10-QQuarterly reportPeriod 2026-03-310001213037-26-000011
2026-04-2316:44 ETDEF 14AProxy statementPeriod 2026-06-110001213037-26-000006
2026-04-0916:10 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-149623
2026-04-0216:15 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors0001193125-26-140152
2026-02-2508:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-068668
2026-02-2417:09 ET8-K2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001193125-26-067476
2026-02-2417:07 ET10-KAnnual reportPeriod 2025-12-310001193125-26-067464
2026-01-2716:01 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-024375
2025-11-0616:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-25-269492
2025-11-0616:00 ET10-QQuarterly reportPeriod 2025-09-300001193125-25-269424
2025-07-2916:10 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events0000950170-25-099631
2025-07-2916:00 ET10-QQuarterly reportPeriod 2025-06-300000950170-25-099610
2025-06-2616:30 ET8-K5.07 Shareholder vote results0001641172-25-016659
2025-06-1716:15 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-25-087369
2025-05-0816:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-066947
2025-05-0816:00 ET10-QQuarterly reportPeriod 2025-03-310000950170-25-066886
2025-04-2916:00 ETDEF 14AProxy statementPeriod 2025-04-290000950170-25-060074
2025-02-2716:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-25-029065
2025-02-2716:00 ET10-KAnnual reportPeriod 2024-12-310000950170-25-028992
2025-01-0616:10 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0000950170-25-002076
2024-12-1016:10 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-134970
2024-12-1006:02 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-24-134749
2024-11-0716:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-24-123303
2024-11-0716:00 ET10-QQuarterly reportPeriod 2024-09-300000950170-24-123242
2024-08-0816:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-24-036122
2024-08-0816:00 ET10-QQuarterly reportPeriod 2024-06-300001628280-24-036098
2024-06-2016:03 ET8-K5.07 Shareholder vote results0001628280-24-029108
2024-06-0316:03 ET8-K5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001628280-24-026295
2024-05-0216:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-24-020010
2024-05-0216:00 ET10-QQuarterly reportPeriod 2024-03-310001628280-24-019974
2024-04-2516:02 ETDEF 14AProxy statementPeriod 2024-06-200001628280-24-018143
2024-04-0816:07 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-24-015247
2024-02-2916:08 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-24-007972
2024-02-2916:00 ET10-KAnnual reportPeriod 2023-12-310001628280-24-007948
2024-01-0809:12 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-24-000780
2023-11-0216:06 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-23-036386

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:10 ET. Listed shows no prices and gives no investment advice.